Globe Newswire
SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired The Chemours Company (NYSE: CC) common stock between February 10, 2023 and February 28, 2024. Chemours is an industrial and specialty chemical company for a number of markets including, among others, the “coatings, plastics, refrigeration and air conditioning, transportation,... (continue reading...)
SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Plug Power Inc. (NASDAQ: PLUG) securities between May 9, 2023 and January 16, 2024. Plug provides hydrogen fuel cell turnkey solutions for the electric mobility and stationary power markets in North America and Europe, focusing on proton exchange membrane (“PEM”) fuel cell and... (continue reading...)
SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Shoals Technologies Group, Inc. (NASDAQ: SHLS) common stock between May 17, 2022 and November 7, 2023. Shoals purports to be a leading provider of electrical balance of system (“EBOS”) products for solar power generation, battery storage, and electric vehicle charging... (continue reading...)
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to complete a Non-Brokered Private Placement offering (the “Private Placement”) of up to $500,000. The Company... (continue reading...)
All amounts expressed in United States dollars (US$) unless otherwise noted
TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- FG Acquisition Corp. (TSX: FGAA.U, FGAA.WT.U) (“FGAC” or the “Corporation”), a special purpose acquisition company, and Strong Global Entertainment, Inc. (NYSE: SGE) (“Strong Global”) are pleased to announce the proposed acquisition (the “MDI Acquisition”) of Strong/MDI Screen Systems, Inc. (“MDI”) by FGAC, pursuant to an... (continue reading...)
More Globe Newswire
View Older Stories-
LGI Homes, Inc. Reports April 2024 Home Closings
-
American Oncology Network Announces CFO Transition
-
Millicom (Tigo) share repurchase activity
-
Jeff Cook Real Estate LPT Realty Named A Winner of the South Carolina Top Workplaces 2024 Award for Sixth Consecutive Year
-
MarketWise Declares Dividend on Common Stock
-
Newbury Street Acquisition Corporation Announces Receipt of Nasdaq Letter
-
Global Helium Corp. Grants Stock Options
-
Gran Tierra Energy Announces Final Voting Results of its Annual Meeting of Stockholders
-
AGF Reports April 2024 Assets Under Management and Fee-Earning Assets
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
StakingFarm Expands Crypto Frontier with Launch of Innovative Bitcoin Staking Platform
-
INVESTOR ALERT: DiCello Levitt LLP Announces Shareholder Class Action Against Malibu Boats, Inc. (NASDAQ: MBUU); Investors with Losses Encouraged to Seek Counsel
-
Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Territorial Bancorp Inc. Announces First Quarter 2024 Results
-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to June 3, 2024
-
Cornerstone Funds Announce Continuing Monthly Distributions
-
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
-
Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units
-
Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b)(1)
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
CNH announces voting results of 2024 Annual General Meeting and publishes 2023 Sustainability Report
-
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Exscientia plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – EXAI
-
Enstar Group Limited Announces Quarterly Preference Share Dividends
-
Hudson Global to Report First Quarter 2024 Financial Results on May 10th
-
Global Ship Lease Announces Annual Meeting of Shareholders
-
Signing Day Sports Provides Announcement on Its Annual Report
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
-
Bel Fuse Announces Upcoming Investor Conference Schedule for May 2024
-
Taitron Announces Quarterly Cash Dividend
-
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
-
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
-
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
S Split Corp. Declares Monthly Distribution
-
Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly Distribution
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for its ETF Class
-
Infinite Reality’s SPAC Partner Engages BTIG as Capital Markets Advisor; Continues to Drive Robust Expansion and Strengthened Market Position
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
OriginTrail Decentralized Knowledge Graph for trusted cross-organization real-time data integration in EU-funded DMaaST
-
OriginTrail Decentralized Knowledge Graph for trusted cross-organization real-time data integration in EU-funded DMaaST
-
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)